The rapid expansion, accessibility, and enhancement to real-world clinical data like electronic health records, genomic sequencing data, and patient reported outcomes coupled with improvements in technology and analytical applications has opened the door to new fields of opportunity to help transform the fight against cancer.  To effectively harness these data’s potential – and to positively impact the patient experience – products need to be developed to effectively evolve with the changing continuum of cancer care.

Topics covered:

  • Vision for real-world data in oncology
  • Current paradigm of oncology product development lifecycle
  • Evolution of real-world data & changing data landscape (data sources, data access and data enhancements)
  • Opportunities to increase usage of real-world data across the product development life cycle 
  • Direct impact of real-world data and its future influence

Featured Speakers

Sarah A. Alwardt, PhD

Vice President, Real World Research

A highly accomplished leader with domestic and international experience in health economics and outcomes research, research and development, operations, analytics, and technology innovation, Sarah has proven success in organizational transformation, business acceleration, and delivering data driven insights and evidence. She is an accomplished author having published and presented several works in real world evidence applications and speaks frequently on the challenges and opportunities of real world evidence and research collaboration between Fortune 100 companies. Sarah holds Bachelor’s, Master’s, and Doctoral degrees in Chemical Engineering and a Certificate in Environmental Engineering all from the University of Louisville’s Speed School of Engineering.

Nicholas Robert, MD

Vice President, Medical Affairs

A graduate of the McGill Medical School, Dr. Robert completed an Internship and Residency in Internal Medicine at the Royal Victoria Hospital in Montreal.  Following a residency in Anatomic Pathology at Massachusetts General Hospital, he continued his training in Hematology at Brigham and Women’s Hospital and in Medical Oncology at Dana Farber Cancer Institute. He was a Fellow at Harvard Medical School. His experience includes Clinical Director of Medical Oncology at New England Medical Center, Medical Director of the Research Program of Virginia Cancer Specialists, Chief of the Section of Hematology/Oncology and Chairman of the Cancer Committee of the Inova Fairfax Hospital and Chairman of the Cancer Committee as well as the Chairman of the ECOG Breast Committee and Co-chair of the Breast Committee of the US Oncology Research Network.

Jocelyn Benson, MPH

Senior Director, Clinical Data Services

Jocelyn joined Ontada after working as an epidemiologist for the Department of State Health Services for Texas in COVID-19 response.  Prior, Jocelyn was Director of Clinical Data (Abstraction) at Flatiron Health, Associate Director of Business Intelligence at Planned Parenthood Federation of America and a Consultant with The Frankel Group, a healthcare strategy consultancy.  Her career has been primarily in curating, narrating and leveraging healthcare data for operational impact strategic decision making. Jocelyn has an MPH from Yale University and BA from Wellesley College.

David M. Waterhouse, MD, MPH

Medical Oncology, Hematology
OHC in Cincinnati (Specialists in Cancer and Blood Disorders)

Dr. Waterhouse is a medical oncologist and hematologist whose specialties include lung cancer and urologic cancer. Dr. Waterhouse is passionate about real-world cancer research and the impact it has on patients. This is evidenced by his extensive commitments: as Chair of the Research Community Forum of the American Society of Clinical Oncology (ASCO), as Co-Director of OHC’s Research Department, and as Principal Investigator for lung cancer trials at OHC. Dr. Waterhouse completed Medical School and his Residency at the University of Massachusetts Medical School in Boston. His Fellowship was at the University of Michigan, Ann Arbor, MI. He also received his Master of Science in Public Health at the University of Michigan.  He has collaborated on, and published, multiple real-world (HEOR) research initiatives.